Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Human epidermal growth factor receptor 2 inhibitor | Is a | Protein-tyrosine kinase inhibitor | false | Inferred relationship | Some | ||
| Human epidermal growth factor receptor 2 inhibitor | Has disposition (attribute) | Human epidermal growth factor receptor 2 inhibitor | true | Inferred relationship | Some | ||
| Human epidermal growth factor receptor 2 inhibitor | Is a | Epidermal growth factor receptor inhibitor | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trastuzumab (substance) | Is a | True | Human epidermal growth factor receptor 2 inhibitor | Inferred relationship | Some | |
| Pertuzumab | Is a | True | Human epidermal growth factor receptor 2 inhibitor | Inferred relationship | Some | |
| Trastuzumab emtansine | Is a | True | Human epidermal growth factor receptor 2 inhibitor | Inferred relationship | Some | |
| Trastuzumab deruxtecan | Is a | True | Human epidermal growth factor receptor 2 inhibitor | Inferred relationship | Some | |
| Margetuximab (substance) | Is a | True | Human epidermal growth factor receptor 2 inhibitor | Inferred relationship | Some | |
| Receptor tyrosine-protein kinase erbB-2 inhibitor therapy (procedure) | Direct substance | True | Human epidermal growth factor receptor 2 inhibitor | Inferred relationship | Some | 1 |
| Lapatinib (substance) | Is a | True | Human epidermal growth factor receptor 2 inhibitor | Inferred relationship | Some |
This concept is not in any reference sets